BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 1992;42:951-6. [PMID: 1453586 DOI: 10.1038/ki.1992.372] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Winter KR, Stoffregen WC, Dean-Nystrom EA. Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes. Infect Immun 2004;72:6680-4. [PMID: 15501802 DOI: 10.1128/IAI.72.11.6680-6684.2004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
2 Holcombe RF, Baethge BA, Wolf RE, Betzing KW, Stewart RM, Hall VC, Fukuda M. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus. Lupus 1994;3:97-102. [PMID: 7920621 DOI: 10.1177/096120339400300207] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
3 Galbusera M, Benigni A, Paris S, Ruggenenti P, Zoja C, Rossi C, Remuzzi G. Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. J Am Soc Nephrol 1999;10:1234-41. [PMID: 10361861 DOI: 10.1681/ASN.V1061234] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Bonvicini F, Pagnotta E, Punzo A, Calabria D, Simoni P, Mirasoli M, Passerini N, Bertoni S, Ugolini L, Lazzeri L, Gentilomi GA, Caliceti C, Roda A. Effect of Lactobacillus acidophilus Fermented Broths Enriched with Eruca sativa Seed Extracts on Intestinal Barrier and Inflammation in a Co-Culture System of an Enterohemorrhagic Escherichia coli and Human Intestinal Cells. Nutrients 2020;12:E3064. [PMID: 33036498 DOI: 10.3390/nu12103064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Robson WL. Haemolytic uraemic syndrome. Paediatr Drugs 2000;2:243-52. [PMID: 10946413 DOI: 10.2165/00128072-200002040-00001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Fernandez GC, Gomez SA, Ramos MV, Bentancor LV, Fernandez-brando RJ, Landoni VI, Lopez L, Ramirez F, Diaz M, Alduncin M, Grimoldi I, Exeni R, Isturiz MA, Palermo MS. The Functional State of Neutrophils Correlates With the Severity of Renal Dysfunction in Children With Hemolytic Uremic Syndrome. Pediatr Res 2007;61:123-8. [DOI: 10.1203/01.pdr.0000250037.47169.55] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
7 Nishimoto G, Tsunoda Y, Nagata M, Yamaguchi Y, Yoshioka T, Ito K. Acute renal failure associated withCandida albicans infection. Pediatr Nephrol 1995;9:480-2. [DOI: 10.1007/bf00866734] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Inward CD, Pall AA, Adu D, Milford DV, Taylor CM. Soluble circulating cell adhesion molecules in haemolytic uraemic syndrome. Pediatr Nephrol 1995;9:574-8. [DOI: 10.1007/bf00860938] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Chaisri U, Nagata M, Kurazono H, Horie H, Tongtawe P, Hayashi H, Watanabe T, Tapchaisri P, Chongsa-nguan M, Chaicumpa W. Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microbial Pathogenesis 2001;31:59-67. [DOI: 10.1006/mpat.2001.0447] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
10 Stone SM, Thorpe CM, Ahluwalia A, Rogers AB, Obata F, Vozenilek A, Kolling GL, Kane AV, Magun BE, Jandhyala DM. Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib. Front Cell Infect Microbiol 2012;2:135. [PMID: 23162799 DOI: 10.3389/fcimb.2012.00135] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
11 Harrison LM, van den Hoogen C, van Haaften WC, Tesh VL. Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides. Infect Immun 2005;73:403-12. [PMID: 15618178 DOI: 10.1128/IAI.73.1.403-412.2005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
12 Westerholt S, Hartung T, Tollens M, Güstrau A, Oberhoffer M, Karch H, Klare B, Pfeffer K, Emmrich P, Oberhoffer R. Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues. Cytokine 2000;12:822-7. [PMID: 10843773 DOI: 10.1006/cyto.1999.0624] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
13 Masri C, Proulx F, Toledano B, Clermont M, Mariscalco MM, Seidman EG, Carcillo J. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7–associated hemolytic uremic syndrome. American Journal of Kidney Diseases 2000;36:687-94. [DOI: 10.1053/ajkd.2000.17612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lee KS, Jeong YJ, Lee MS. Escherichia coli Shiga Toxins and Gut Microbiota Interactions. Toxins (Basel) 2021;13:416. [PMID: 34208170 DOI: 10.3390/toxins13060416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Andreoli SP. The pathophysiology of the hemolytic uremic syndrome: . Current Opinion in Nephrology and Hypertension 1999;8:459-64. [DOI: 10.1097/00041552-199907000-00010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
16 Buteau C, Proulx F, Chaibou M, Raymond D, Clermont MJ, Mariscalco MM, Lebel MH, Seidman E. Leukocytosis in children with Escherichia coli O157:H7 enteritis developing the hemolytic-uremic syndrome. Pediatr Infect Dis J 2000;19:642-7. [PMID: 10917223 DOI: 10.1097/00006454-200007000-00012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
17 King AJ. Acute inflammation in the pathogenesis of hemolytic-uremic syndrome. Kidney International 2002;61:1553-64. [DOI: 10.1046/j.1523-1755.2002.00281.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
18 Taguchi T, Uchida H, Kiyokawa N, Mori T, Sato N, Horie H, Takeda T, Fujimoto J. Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney International 1998;53:1681-8. [DOI: 10.1046/j.1523-1755.1998.00939.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 3.6] [Reference Citation Analysis]
19 Zoja C, Angioletti S, Donadelli R, Zanchi C, Tomasoni S, Binda E, Imberti B, te Loo M, Monnens L, Remuzzi G. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Kidney Int. 2002;62:846-856. [PMID: 12164866 DOI: 10.1046/j.1523-1755.2002.00503.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 4.6] [Reference Citation Analysis]
20 Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998;11:450-79. [PMID: 9665978 DOI: 10.1128/CMR.11.3.450] [Cited by in Crossref: 936] [Cited by in F6Publishing: 357] [Article Influence: 39.0] [Reference Citation Analysis]
21 Oda T, Hotta O, Taguma Y, Kitamura H, Sudo K, Horigome I, Chiba S, Yoshizawa N, Nagura H. Involvement of neutrophil elastase in crescentic glomerulonephritis. Hum Pathol 1997;28:720-8. [PMID: 9191007 DOI: 10.1016/s0046-8177(97)90182-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
22 Proulx F, Turgeon JP, Litalien C, Mariscalco MM, Robitaille P, Seidman E. Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome. Pediatr Infect Dis J 1998;17:899-904. [PMID: 9802632 DOI: 10.1097/00006454-199810000-00010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 2.2] [Reference Citation Analysis]
23 Inward CD, Varagunam M, Adu D, Milford DV, Taylor CM. Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection. Arch Dis Child 1997;77:145-7. [PMID: 9301354 DOI: 10.1136/adc.77.2.145] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 2.2] [Reference Citation Analysis]
24 Taylor C. Verocytotoxin-producing Escherichia coli and the haemolytic uraemic syndrome. Journal of Infection 1995;30:189-92. [DOI: 10.1016/s0163-4453(95)90601-0] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
25 Roche JK, Keepers TR, Gross LK, Seaner RM, Obrig TG. CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am J Pathol 2007;170:526-37. [PMID: 17255321 DOI: 10.2353/ajpath.2007.060366] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
26 Taylor CM, Monnens LA. Advances in haemolytic uraemic syndrome. Arch Dis Child 1998;78:190-3. [PMID: 9579168 DOI: 10.1136/adc.78.2.190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
27 Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol. 1994;55:97-179. [PMID: 8304236 DOI: 10.1016/s0065-2776(08)60509-x] [Cited by in Crossref: 1481] [Cited by in F6Publishing: 1] [Article Influence: 52.9] [Reference Citation Analysis]
28 Sansonetti PJ, Jacewicz MS, Acheson DWK, Binion DG, West GA, Lincicome LL, Fiocchi C, Keusch GT. Responses of Human Intestinal Microvascular Endothelial Cells to Shiga Toxins 1 and 2 and Pathogenesis of Hemorrhagic Colitis. Infect Immun 1999;67:1439-44. [DOI: 10.1128/iai.67.3.1439-1444.1999] [Cited by in Crossref: 62] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
29 Siegler RL, Pysher TJ. NF-kappaB and neutrophils in post-diarrheal HUS. Kidney Int 2002;62:1088-90. [PMID: 12164895 DOI: 10.1046/j.1523-1755.2002.00541.x] [Reference Citation Analysis]
30 Yamamoto ET, Mizuno M, Nishikawa K, Miyazawa S, Zhang L, Matsuo S, Natori Y. Shiga toxin 1 causes direct renal injury in rats. Infect Immun 2005;73:7099-106. [PMID: 16239503 DOI: 10.1128/IAI.73.11.7099-7106.2005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
31 Stefanescu R, Bassett D, Modarresi R, Santiago F, Fakruddin M, Laurence J. Synergistic interactions between interferon-gamma and TRAIL modulate c-FLIP in endothelial cells, mediating their lineage-specific sensitivity to thrombotic thrombocytopenic purpura plasma-associated apoptosis. Blood 2008;112:340-9. [PMID: 18339897 DOI: 10.1182/blood-2007-10-119552] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
32 Tovaglieri A, Sontheimer-Phelps A, Geirnaert A, Prantil-Baun R, Camacho DM, Chou DB, Jalili-Firoozinezhad S, de Wouters T, Kasendra M, Super M, Cartwright MJ, Richmond CA, Breault DT, Lacroix C, Ingber DE. Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites. Microbiome 2019;7:43. [PMID: 30890187 DOI: 10.1186/s40168-019-0650-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 16.0] [Reference Citation Analysis]
33 Karpman D, Ståhl AL. Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response. Microbiol Spectr 2014;2. [PMID: 26104359 DOI: 10.1128/microbiolspec.EHEC-0009-2013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
34 Fernández GC, Rubel C, Dran G, Gómez S, Isturiz MA, Palermo MS. Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome. Clin Immunol 2000;95:227-34. [PMID: 10866130 DOI: 10.1006/clim.2000.4862] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
35 Heyderman RS, Soriani M, Hirst TR. Is immune cell activation the missing link in the pathogenesis of post-diarrhoeal HUS? Trends Microbiol 2001;9:262-6. [PMID: 11390240 DOI: 10.1016/s0966-842x(01)02045-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
36 Yamasaki C, Natori Y, Zeng X, Ohmura M, Yamasaki S, Takeda Y, Natori Y. Induction of cytokines in a human colon epithelial cell line by Shiga toxin 1 (Stx1) and Stx2 but not by non-toxic mutant Stx1 which lacks N -glycosidase activity. FEBS Letters 1999;442:231-4. [DOI: 10.1016/s0014-5793(98)01667-6] [Cited by in Crossref: 74] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
37 Proulx F, Seidman EG, Karpman D. Pathogenesis of Shiga Toxin-Associated Hemolytic Uremic Syndrome. Pediatr Res 2001;50:163-71. [DOI: 10.1203/00006450-200108000-00002] [Cited by in Crossref: 139] [Cited by in F6Publishing: 126] [Article Influence: 6.6] [Reference Citation Analysis]
38 te Loo DMWM, Monnens LAH, van der Velden TJAM, Vermeer MA, Preyers F, Demacker PNM, van den Heuvel LPWJ, van Hinsbergh VWM. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 2000;95:3396-402. [DOI: 10.1182/blood.v95.11.3396.011k19_3396_3402] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
39 Taylor CM, Williams JM, Lote CJ, Howie AJ, Thewles A, Wood JA, Milford DV, Raafat F, Chant I, Rose PE. A laboratory model of toxin-induced hemolytic uremic syndrome. Kidney International 1999;55:1367-74. [DOI: 10.1046/j.1523-1755.1999.00387.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
40 Brigotti M. The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? Toxins (Basel) 2012;4:157-90. [PMID: 22741061 DOI: 10.3390/toxins4030157] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
41 van Setten PA, van Hinsbergh VW, van der Velden TJ, van de Kar NC, Vermeer M, Mahan JD, Assmann KJ, van den Heuvel LP, Monnens LA. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 1997;51:1245-56. [PMID: 9083293 DOI: 10.1038/ki.1997.170] [Cited by in Crossref: 137] [Cited by in F6Publishing: 134] [Article Influence: 5.5] [Reference Citation Analysis]
42 Hurley BP, Thorpe CM, Acheson DW. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect Immun 2001;69:6148-55. [PMID: 11553554 DOI: 10.1128/IAI.69.10.6148-6155.2001] [Cited by in Crossref: 115] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
43 Biernbaum EN, Kudva IT. AB5 Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins. Toxins (Basel) 2022;14:62. [PMID: 35051039 DOI: 10.3390/toxins14010062] [Reference Citation Analysis]
44 Fernandez GC, Lopez MF, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Dran GI, Meiss R, Isturiz MA, Palermo MS. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol 2006;146:76-84. [PMID: 16968401 DOI: 10.1111/j.1365-2249.2006.03155.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
45 Palermo M, Alves-Rosa F, Rubel C, Fernández GC, Fernández-Alonso G, Alberto F, Rivas M, Isturiz M. Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 2000;119:77-83. [PMID: 10606967 DOI: 10.1046/j.1365-2249.2000.01103.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
46 te Loo DMWM, Monnens LAH, van der Velden TJAM, Vermeer MA, Preyers F, Demacker PNM, van den Heuvel LPWJ, van Hinsbergh VWM. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 2000;95:3396-402. [DOI: 10.1182/blood.v95.11.3396] [Cited by in Crossref: 136] [Article Influence: 6.2] [Reference Citation Analysis]
47 Tsang T, Tam P. Cytokine response of neonates to surgery. Journal of Pediatric Surgery 1994;29:794-7. [DOI: 10.1016/0022-3468(94)90373-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
48 Zoja C, Locatelli M, Pagani C, Corna D, Zanchi C, Isermann B, Remuzzi G, Conway EM, Noris M. Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice. J Immunol 2012;189:3661-8. [PMID: 22942429 DOI: 10.4049/jimmunol.1102118] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
49 Lee JE, Kim JS, Choi IH, Tagawa M, Kohsaka T, Jin DK. Cytokine expression in the renal tubular epithelial cells stimulated by Shiga toxin 2 of Escherichia coli O157:H7. Ren Fail 2002;24:567-75. [PMID: 12380901 DOI: 10.1081/jdi-120013959] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
50 Heyderman R, Fitzpatrick M, Barclay G, Reymond D, Bianchetti M, Burnens A, Lior H, Cochran M, Coates P. Haemolytic-uraemic syndrome. The Lancet 1994;343:1042-3. [DOI: 10.1016/s0140-6736(94)90165-1] [Cited by in Crossref: 21] [Article Influence: 0.8] [Reference Citation Analysis]
51 Bitzan M, Lapeyraque A. Postinfectious Hemolytic Uremic Syndrome. In: Geary DF, Schaefer F, editors. Pediatric Kidney Disease. Berlin: Springer Berlin Heidelberg; 2016. pp. 653-731. [DOI: 10.1007/978-3-662-52972-0_26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
52 van de Kar N, Monnens L. 15 The haemolytic-uraemic syndrome in childhood. Baillière's Clinical Haematology 1998;11:497-507. [DOI: 10.1016/s0950-3536(98)80063-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
53 Yamazaki H, Hiramatsu N, Hayakawa K, Tagawa Y, Okamura M, Ogata R, Huang T, Nakajima S, Yao J, Paton AW, Paton JC, Kitamura M. Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J Immunol 2009;183:1480-7. [PMID: 19561103 DOI: 10.4049/jimmunol.0900017] [Cited by in Crossref: 176] [Cited by in F6Publishing: 171] [Article Influence: 13.5] [Reference Citation Analysis]
54 Lewis SB, Prior A, Ellis SJ, Cook V, Chan SS, Gelson W, Schüller S. Flagellin Induces β-Defensin 2 in Human Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli. Front Cell Infect Microbiol 2016;6:68. [PMID: 27446815 DOI: 10.3389/fcimb.2016.00068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
55 Harrison LM, Gaines DW, Babu US, Balan KV, Reimschuessel R, Do AB, Pereira MR, Bigley EC 3rd, Ferguson M, Mehta A, Williams KM. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2. Microb Pathog 2018;123:250-8. [PMID: 30016681 DOI: 10.1016/j.micpath.2018.07.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Zoja C, Buelli S, Morigi M. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr Nephrol 2010;25:2231-40. [DOI: 10.1007/s00467-010-1522-1] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 10.6] [Reference Citation Analysis]
57 Rogers TJ, Paton AW, McColl SR, Paton JC. Enhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli. Infect Immun 2003;71:5623-32. [PMID: 14500482 DOI: 10.1128/IAI.71.10.5623-5632.2003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
58 Siegler RL. The Hemolytic Uremic Syndrome. Pediatric Clinics of North America 1995;42:1505-29. [DOI: 10.1016/s0031-3955(16)40096-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
59 Maroeska Te Loo D, Bosma N, Van Hinsbergh V, Span P, De Waal R, Clarijs R, Sweep C, Monnens L, Van Den Heuvel L. Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS. Pediatr Nephrol 2004;19:754-60. [PMID: 15141341 DOI: 10.1007/s00467-004-1475-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
60 Proulx F, Toledano B, Phan V, Clermont M, Mariscalco MM, Seidman EG. Circulating Granulocyte Colony-Stimulating Factor, C-X-C, and C-C Chemokines in Children with Escherichia Coli O157:H7 Associated Hemolytic Uremic Syndrome. Pediatr Res 2002;52:928-34. [DOI: 10.1203/00006450-200212000-00019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
61 Vanaja SK, Jandhyala DM, Mallick EM, Leong JM, Balasubramanian S. Enterohemorrhagic and other Shigatoxin-producing Escherichia coli. Escherichia coli. Elsevier; 2013. pp. 121-82. [DOI: 10.1016/b978-0-12-397048-0.00005-x] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
62 Rennke HG. Secondary membranoproliferative glomerulonephritis. Kidney Int 1995;47:643-56. [PMID: 7723253 DOI: 10.1038/ki.1995.82] [Cited by in Crossref: 87] [Cited by in F6Publishing: 57] [Article Influence: 3.2] [Reference Citation Analysis]
63 Karpman D, Andreasson A, Thysell H, Kaplan BS, Svanborg C. Cytokines in childhood hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Pediatr Nephrol 1995;9:694-9. [DOI: 10.1007/bf00868714] [Cited by in Crossref: 88] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
64 Obrig TG, Karpman D. Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol 2012;357:105-36. [PMID: 21983749 DOI: 10.1007/82_2011_172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
65 García A, Marini RP, Catalfamo JL, Knox KA, Schauer DB, Rogers AB, Fox JG. Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits. Microbes and Infection 2008;10:650-6. [DOI: 10.1016/j.micinf.2008.03.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
66 Proulx F, Litalien C, Turgeon JP, Mariscalco MM, Seidman E. Circulating levels of transforming growth factor-beta1 and lymphokines among children with hemolytic uremic syndrome. Am J Kidney Dis 2000;35:29-34. [PMID: 10620540 DOI: 10.1016/s0272-6386(00)70297-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
67 Szabady RL, Lokuta MA, Walters KB, Huttenlocher A, Welch RA. Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7. PLoS Pathog 2009;5:e1000320. [PMID: 19247439 DOI: 10.1371/journal.ppat.1000320] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
68 Ramos MV, Auvynet C, Poupel L, Rodero M, Mejias MP, Panek CA, Vanzulli S, Combadiere C, Palermo M. Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome. Am J Pathol 2012;180:1040-8. [PMID: 22203055 DOI: 10.1016/j.ajpath.2011.11.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
69 Gobert AP, Coste A, Guzman CA, Vareille M, Hindré T, de Sablet T, Girardeau JP, Martin C. Modulation of chemokine gene expression by Shiga-toxin producing Escherichia coli belonging to various origins and serotypes. Microbes Infect 2008;10:159-65. [PMID: 18248761 DOI: 10.1016/j.micinf.2007.10.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
70 Bielaszewska M, Marejková M, Bauwens A, Kunsmann-Prokscha L, Mellmann A, Karch H. Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB. Int J Med Microbiol 2018;308:882-9. [PMID: 29934223 DOI: 10.1016/j.ijmm.2018.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
71 Vareille M, de Sablet T, Hindré T, Martin C, Gobert AP. Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A 2007;104:10199-204. [PMID: 17537918 DOI: 10.1073/pnas.0702589104] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
72 Ray P, Acheson D, Chitrakar R, Cnaan A, Gibbs K, Hirschman GH, Christen E, Trachtman H. Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome. J Am Soc Nephrol 2002;13:699-707. [PMID: 11856774 DOI: 10.1681/ASN.V133699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
73 Nash MC, Dillon MJ. Antineutrophil cytoplasm antibodies and vasculitis. Arch Dis Child 1997;77:261-4. [PMID: 9370911 DOI: 10.1136/adc.77.3.261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
74 Rao WH, Evans GS, Finn A. The significance of interleukin 8 in urine. Arch Dis Child 2001;85:256-62. [PMID: 11517116 DOI: 10.1136/adc.85.3.256] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
75 Brigotti M, Carnicelli D, Arfilli V, Porcellini E, Galassi E, Valerii MC, Spisni E. Human monocytes stimulated by Shiga toxin 1a via globotriaosylceramide release proinflammatory molecules associated with hemolytic uremic syndrome. Int J Med Microbiol 2018;308:940-6. [PMID: 29983334 DOI: 10.1016/j.ijmm.2018.06.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
76 Pisoni R, Ruggenenti P, Remuzzi G. Drug-Induced Thrombotic Microangiopathy: Incidence, Prevention and Management. Drug Safety 2001;24:491-501. [DOI: 10.2165/00002018-200124070-00002] [Cited by in Crossref: 78] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]
77 Khalid M, Andreoli S. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol 2019;34:2495-507. [PMID: 30382336 DOI: 10.1007/s00467-018-4105-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
78 Rogers TJ, Paton JC, Wang H, Talbot UM, Paton AW. Reduced virulence of an fliC mutant of Shiga-toxigenic Escherichia coli O113:H21. Infect Immun 2006;74:1962-6. [PMID: 16495575 DOI: 10.1128/IAI.74.3.1962-1966.2006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
79 van Setten PA, van Hinsbergh VW, van den Heuvel LP, Preyers F, Dijkman HB, Assmann KJ, van der Velden TJ, Monnens LA. Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res 1998;43:759-67. [PMID: 9621985 DOI: 10.1203/00006450-199806000-00008] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 3.3] [Reference Citation Analysis]
80 Moake JL. Haemolytic-uraemic syndrome: basic science. Lancet. 1994;343:393-397. [PMID: 7905556 DOI: 10.1016/s0140-6736(94)91227-0] [Cited by in Crossref: 123] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
81 Zou D, Meng X, Wang B, Dai Y, Yang R, Suo Y, Wu Y, Yang W, Lin R. Analysis of pharmacological mechanisms and targets mining of Wuzi-Yanzong-Wan for treating non-obstructive oligoasthenospermia. Biomedicine & Pharmacotherapy 2019;115:108898. [DOI: 10.1016/j.biopha.2019.108898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Brigotti M, Carnicelli D, Ravanelli E, Vara AG, Martinelli C, Alfieri RR, Petronini PG, Sestili P. Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin. Infect Immun 2007;75:2201-7. [PMID: 17296757 DOI: 10.1128/IAI.01707-06] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
83 Griener TP, Strecker JG, Humphries RM, Mulvey GL, Fuentealba C, Hancock RE, Armstrong GD. Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2. PLoS One 2011;6:e21457. [PMID: 21731756 DOI: 10.1371/journal.pone.0021457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
84 Thorpe CM, Ritchie JM, Acheson DW. Enterohemorrhagic and Other Shiga Toxin–Producing Escherichia coli. Escherichia Coli. Elsevier; 2002. pp. 119-54. [DOI: 10.1016/b978-012220751-8/50005-7] [Cited by in Crossref: 11] [Article Influence: 0.6] [Reference Citation Analysis]